John Craig Thompson, Chief Commercial Officer at Trius Therapeutics Inc (TSRX), bought 133 shares at $6.48 ($862) on 2011-08-22, disclosed to the SEC on 2011-08-24.
Open-market purchase of $862 TSRX by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TTPH | SELL | 2015-08-07 | $463K | — | Filing → |
| TTPH | SELL | 2015-07-08 | $479K | — | Filing → |
| TTPH | SELL | 2015-06-16 | $415K | — | Filing → |